tiprankstipranks
Sophia Genetics initiated with a Buy at BTIG
The Fly

Sophia Genetics initiated with a Buy at BTIG

BTIG analyst Mark Massaro initiated coverage of Sophia Genetics with a Buy rating and $6.00 price target. The analyst states that he is impressed by the company’s strong financial profile given its above 90% recurring revenue and targeting 30%-35% topline CAGR with above 70% in gross margins by 2025. Most of Sophia Genetics’ revenue is in Europe today, but the company should make further inroads into the U.S. market, Massaro tells investors in a research note, stating that he sees "significant upside potential" for this stock which he believes to be "disconnected from its fundamentals".

Published first on TheFly

See the top stocks recommended by analysts >>

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100
Bitcoin

Popular Articles